Medicinal Products

Dáil Éireann Debate, Thursday - 26 March 2026

• Díospóireachtaí
• Aimsigh díospóireacht
  • Díospóireachtaí na Dála
  • Díospóireachtaí an tSeanaid
  • Díospóireachtaí Coiste
• Aimsigh vótáil
  • Vótálacha na Dála
  • Vótálacha an tSeanaid
  • Vótálacha Coiste
• Ceisteanna Parlaiminte
  • Ceisteanna scríofa
  • Ceisteanna ó bhéal
• Leideanna cuardaigh
• Nuair a bhíonn tionchar tromchúiseach ag aithrisí

Thursday, 26 March 2026

Ceisteanna (462)

Pádraig Rice

Ceist:

462. Deputy Pádraig Rice asked the Minister for Health to provide a list of ICS–formoterol combination inhalers currently reimbursed under the general medical services (GMS) scheme, including whether they are approved for use as maintenance and reliever therapy (MART); and if she will make a statement on the matter. [23298/26]

Freagraí scríofa

Minister for Health

As this is a service matter and under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices, this question has been referred to the HSE for attention and direct reply to the Deputy.

• An Freagra Roimhe Sin
• An Chéad Fhreagra eile